Are Stem Cell Transplants an Option for Lymphoma Patients with HIV?


People who are HIV positive are at a much greater risk of contracting lymphoma, and around 10 percent of Americans who are HIV infected are expected to develop lymphoma at some point in their lives.

In this video from the Rare Disease Report, shared in December 2014,  Dr. Joseph Alvarnas from the City of Hope Medical Center in Duarte, California, discusses in detail the very promising results of a clinical trial of autologous hematopoietic stem cell transplants (AHCT) in HIV patients with Hodgkin’s and non-Hodgkin’s lymphoma.

Find out more about how lymphoma is the leading cause of death among HIV patients. 

“The question was, can we take these patients and offer them autologous transplant … [at] centers that don’t normally manage HIV patients? What we found was we could effectively treat these patients with quite excellent outcomes,” Dr. Alvarnas says in the video.

Read a report about this clinical trial, and how patients with HIV-associated lymphoma who receive autologous hematopoietic cell transplants (AHCT) have similar survival and complication rates to non-HIV lymphoma patients.


Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published.